Revance Therapeutics Market Cap

TADAWUL:2320 has a market cap or net worth of 3.61 billion as of August 1, 2025. Its market cap has increased by 53.05% in one year.

Market Cap

3.61B

Enterprise Value

4.45B

Revenue

2.74B

Ranking

n/a

PE Ratio

13.29

Stock Price

$56.40

Market Cap Chart

Since December 12, 2006, TADAWUL:2320's market cap has increased from 1.59B to 3.61B, an increase of 126.40%. That is a compound annual growth rate of 4.48%.

Market Cap History

Date	Market Cap	% Change
Jul 31, 2025	3.61B	44.62%
Dec 31, 2024	2.49B	41.82%
Dec 31, 2023	1.76B	96.80%
Dec 29, 2022	893.55M	-33.46%
Dec 30, 2021	1.34B	-0.47%
Dec 31, 2020	1.35B	17.22%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Kingdom Holding Company	29.83B
The National Shipping Company of Saudi Arabia	20.53B
Riyadh Cables Group Company	19.64B
Makkah Construction and Development Company	16.60B
SAL Saudi Logistics Services Company	13.74B
Flynas Company	12.15B
Astra Industrial Group Company	11.21B
Electrical Industries Company	9.98B

Market Cap Rankings